Meeting Overview - The second extraordinary general meeting of shareholders for East China Pharmaceutical Co., Ltd. is scheduled for December 9, 2025, at 14:00, located at the company's new building in Hangzhou, Zhejiang Province [3][4] - The meeting will utilize a combination of on-site and online voting methods, convened by the board of directors and presided over by the chairman, Lü Liang [4] Attendance Details - A total of 526 shareholders attended the meeting, representing 1,074,532,240 shares, which accounts for 61.2611% of the total voting shares [5] - Among them, 524 small shareholders participated, representing 55,594,083 shares, or 3.1695% of the total voting shares [5] Proposal Voting Results - The proposal to repurchase and cancel part of the restricted stock was approved with 1,074,435,740 votes in favor, representing 99.9910% of the valid votes [7] - The proposal to expand the business scope, change registered capital, and amend the Articles of Association was also approved with 1,074,460,440 votes in favor, representing 99.9933% of the valid votes [8] Legal Opinion - The legal opinion provided by Zhejiang Tian Ce Law Firm confirms that the meeting's convening and voting procedures comply with relevant laws and regulations, and the voting results are valid [9] Stock Repurchase Announcement - The company plans to repurchase and cancel a total of 284,200 shares of restricted stock at a price of 22.85 yuan per share, funded by the company's own resources [12] - Following the repurchase, the total number of shares will decrease from 1,754,021,048 to 1,753,736,848, and the registered capital will reduce from 1,754,021,048 yuan to 1,753,736,848 yuan [13]